Back to Journals » Drug Design, Development and Therapy » Volume 17

Letter

Liquiritin Protects Against Cardiac Fibrosis After Myocardial Fibrosis After Myocardial Infarction by Inhibiting CCL5 Expression and the NF-κB Signaling Pathway [Letter]

       
Total article views   HTML views PDF downloads Totals
2,711 Dovepress* 2,618+ 67 2,685
PubMed Central* 93 42 135
Totals 2,711 109 2,820
*Since 5 February 2023

View citations on PubMed Central and Google Scholar